| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.242 | 7.136 | 7.225 | 7.696 | 1.654 | 1.653 | 5.957 | 5.559 | 8.443 |
| Total Income - EUR | - | 6.242 | 7.136 | 7.225 | 7.696 | 1.654 | 1.653 | 7.156 | 6.272 | 8.443 |
| Total Expenses - EUR | - | 774 | 596 | 238 | 1.576 | 129 | 115 | 2.148 | 2.705 | 3.258 |
| Gross Profit/Loss - EUR | - | 5.467 | 6.541 | 6.987 | 6.120 | 1.525 | 1.538 | 5.008 | 3.567 | 5.185 |
| Net Profit/Loss - EUR | - | 5.280 | 6.326 | 6.770 | 5.889 | 1.475 | 1.492 | 4.829 | 3.065 | 4.372 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Imariflorea Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 762 | 48 | 0 |
| Current Assets | - | 5.375 | 11.624 | 13.685 | 19.091 | 20.135 | 21.226 | 13.549 | 16.624 | 18.044 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 16.858 | 16.539 | 16.207 | 12.390 | 15.757 | 17.005 |
| Cash | - | 5.375 | 11.624 | 13.685 | 2.233 | 3.596 | 5.019 | 1.159 | 867 | 1.039 |
| Shareholders Funds | - | 5.324 | 11.561 | 13.391 | 19.020 | 20.135 | 21.181 | 13.503 | 16.527 | 17.617 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 50 | 63 | 294 | 71 | 0 | 45 | 46 | 96 | 427 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 762 | 48 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8552 - 8552" | |||||||||
| CAEN Financial Year |
8552
|
|||||||||
Comments - Imariflorea Srl